Figure 3From: Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathwayThe expression of EGFR in SKOV3 and CaOV3 cells decreased after JMR-132 treatment. The protein level of EGFR decreased after treatment with 100 nM JMR-132 per day for 2 and 4 days. β-actin was used as an internal control. The data are from one experiment and are representative of the three separate experiments.Back to article page